NCT04040348View on ClinicalTrials.gov

Alzheimer's Disease Stem Cells Multiple Infusions

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 8, 2019

Primary Completion Date

April 25, 2023

Study Completion Date

April 25, 2023

Conditions
Alzheimer Disease
Interventions
BIOLOGICAL

Approximately 100 million cells allogeneic hMSC

Umbilical cord-derived, allogeneic hMSC administered intravenously at a dose of approximately 100 million cells per infusion.

Trial Locations (1)

33136

University of Miami, Miami

All Listed Sponsors
lead

Bernard (Barry) Baumel

OTHER

NCT04040348 - Alzheimer's Disease Stem Cells Multiple Infusions | Biotech Hunter | Biotech Hunter